menu search

Titan Pharmaceuticals Inc. Announces Licensing Agreement with Ocular Therapeutix Inc.

Titan Pharmaceuticals Inc. Announces Licensing Agreement with Ocular Therapeutix Inc.
SAN FRANCISCO, Dec. 12, 2022 (GLOBE NEWSWIRE) — Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“Titan” or the “Company”) today announced that it has granted an exclusive license to Ocular Therapeutix Inc. (“Ocular”) pertaining to certain patent applications for ophthalmic uses in both humans and nonhuman animals in the territory of the United States. Under the terms […] The post Titan Pharmaceuticals Inc. Announces Licensing Agreement with Ocular Therapeutix Inc. appeared first on ForexTV... Read More
Posted: Dec 12 2022, 11:30
Author Name: forextv
Views: 102022

Search within

Pages Search Results: